Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantASTRAZENECA SINGAPORE PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
TABLET, FILM COATED
ORAL
Medical Information
A10BD29
sitagliptin and dapagliflozin
Manufacturer Information
ASTRAZENECA SINGAPORE PTE LTD
SK Chemicals Co, Ltd (1346)
Active Ingredients
Documents
Package Inserts
Sidapvia tablet PI.pdf
Approved: February 20, 2024